Company Overview

Development Stage

About the Company

苏州沪云新药研发股份有限公司是一家基于天然产物进行药物发现和开发的创新驱动型小分子新药研发企业(新三板证券简称苏州沪云,证券代码833464)。沪云始终坚持自主创新发展战略,聚焦于发病机理较为复杂的心脑血管、自身免疫等疾病领域,挖掘传统药用植物资源,解析其中天然产物组分,建立其中特定天然产物与特定疾病之间的联系。
沪云专注于心脑血管(如脑卒中、心衰)、自身免疫(如银屑病、炎症性肠病)等临床需求尚未被满足的疾病领域。沪云目前拥有5个核心研发管线,其中4个已进入临床阶段,1个正在开展Ⅲ期临床,1个正在筹备Ⅱ期临床,1个正处于Ⅰ期临床,1个已获批IND并准备Ⅰ期临床。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

苏州沪云 Financing History (2 rounds)

Manage
定向增发
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1884万人民币
  • Investor: 武汉睿创恒益投资管理有限公...

苏州沪云 How Fast Is Hiring Growing? (11 open positions)

Manage
Note: How fast is hiring at 苏州沪云新药研发股份有限公司 growing? 苏州沪云2025: 1 openings (down 50%), 2024: 2 openings, 2022: 3 openings (down 90%), 2021: 31 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

苏州沪云 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 苏州沪云新药研发股份有限公司? Based on an analysis of 苏州沪云's job postings over the past year, "生物/制药/化工/环保类" demand: 82.4%, "其他(研发和技术类)": 70.6%, "医疗卫生/美容保健类": 70.6%, "科研类": 70.6%. For reference only.

苏州沪云 — What Are the Salaries Like? (17 records)

Manage
salary range: 6K - 50K, 76.5% of roles pay ¥10-20K
Note: salary statistics are based on 17 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 苏州沪云新药研发股份有限公司?苏州沪云76.5% of positions earn 10-20K, Fresh graduate salary: ¥9.0K。生物/制药/化工/环保类 average salary ¥17.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

苏州沪云 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

苏州沪云 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    82.4% of total 82.4%
  • 其他(研发和技术类)
    70.6% of total 70.6%
  • 医疗卫生/美容保健类
    70.6% of total 70.6%
  • 科研类
    70.6% of total 70.6%

Education

  • 硕士
    76.5% of total 76.5%
  • 本科
    23.5% of total 23.5%

Experience

  • 1-3年
    58.8% of total 58.8%
  • 不限
    17.6% of total 17.6%
  • 3-5年
    11.8% of total 11.8%
  • 应届生
    5.9% of total 5.9%
View Detailed Analysis

What does 苏州沪云新药研发股份有限公司 require? Who is 苏州沪云 hiring? 苏州沪云 recruitment: 生物/制药/化工/环保类占比最多占82.4%,其次是其他(研发和技术类)占70.6%. What education can get in at 苏州沪云? 硕士占比最多占76.5%,其次是本科占23.5%. High education required at 苏州沪云? 硕士占76.5%. Work experience required at 苏州沪云? 1-3年占比最多占58.8%,其次是不限占17.6%. Where are the job locations at 苏州沪云? 苏州占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 15,150.9923万(元)
Legal Representative: 李云森
Date Established:
Credit Code: 91320000678339075T
Registered Address: 苏州工业园区华云路1号东坊产业园C区7号楼五楼

People who follow 苏州沪云 also follow

苏州沪云 Competitors (Similar Companies)

软膏剂 医药工业 原料药 制药/药业
“吸入给药技术开发”
生物科技/生物工程 医药 生物医药 CRO
“为全球肿瘤患者带来更好的治疗方案”
制药/药业 医药 医药工业 催化剂
“To make people live longer, healthier, and more vital lives”
“创造更多高效、优质,低价的生物大分子药物”
医药 抗肿瘤药 化学合成药 肿瘤药物
“Health for Humanity, Creating a Better Future Together”
医药 生物医药 原料药 化学原料药
医药 医药中间体 新药研发 仿制药
“A renowned enterprise in China's liver disease and anti-tumor fields”
制药/药业 软膏剂 生物制品 乳膏剂
“Providing solutions for personalized treatment and health management”
“一家专业从事新药研发的高新技术企业”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates